Skip to main content
Jon Cuthbert Profile pIcture
Jon Cuthbert

Jon Cuthbert

GrafaFounder & COO

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.

Articles by Jon Cuthbert

Grafa

Verastem Oncology reports positive RAMP 205 data in front-line pancreatic cancer

Verastem Oncology (NASDAQ:VSTM) today announced positive updated safety and efficacy results from the RAMP 205 Phase 1b/2a Recommended Phase 2 Dose (RP2D) cohort of 29 patients evaluating its investigational combination regimen in first-line metastatic pancreatic ductal adenocarcinoma (PDAC).

Read more: Verastem Oncology reports positive RAMP 205 data in front-line pancreatic cancer